Baltimore, MD, May 6-8, 2010

Abstracts

Accepted Poster Abstracts, K-O

Presenting Author

Poster #

Abstract ID #

Robert Kaper 190 254
A Risk Evaluation and Mitigation Strategy (REMS) to manage the risks of overdose, abuse, addiction, and diversion with rapid-onset opioids
Shweta Kapoor 324 132
A medical records analysis of psychosocial treatment outcomes for chronic pain in a rural Alabama clinical trial
Krisztian Kaszas 195 64
Allosteric modulation of the vanilloid receptor
Nathaniel Katz 188 161
User acceptance and performance assessment of an opioid REMS System: a pilot study
Nathaniel Katz 239 281
Effect of tapering the dose of EMBEDA™ (morphine sulfate and naltrexone hydrochloride) extended release capsules on occurrence of withdrawal symptoms
Nathaniel Katz 240 286
Safety profile of EMBEDA™ (morphine sulfate and naltrexone hydrochloride) extended release capsules in older patients
Myoung Kim 293 220
Design of the Oxycodone Users Registry (OUR): a prospective, multicenter registry of patients with non-malignant pain
Lindsay Kindler 275 55
Analgesic responses for morphine and butorphanol are independent and pain modality specific
Christopher King 217 117
Neuroendocrine and immune responses to individually tailored experimental pain stimuli
Noam Kirson 304 54
Descriptive profile of Medicaid patients with post herpetic neuralgia treated and untreated with lidocaine patch 5%
Anna Kratz 136 172
Pain, depression, and pain interference in the 1st year post amputation: early depressive symptoms predict later pain interference
John Claude Krusz 268 216
IV ketamine treatment for multiple headache and pain disorders
Ruth Landau 109 305
Stability of diffuse noxious inhibitory controls in women: within menstrual cycle fluctuations and across menstrual cycle consistency.
Stephen Landy 244 165
Time to response in patients treated with immediate- and extended-release cyclobenzaprine
Julia Lassegard 235 12
Trigeminal peripheral sensitization from endoscopic foreheadplasty surgery
Daniel Lee 311 190
Gabapentin enacarbil improves pain associated with Restless Legs Syndrome (RLS)
Sylvie LeMay 238 181
Combination of analgesics for pain management of children presenting to the ED with a limb trauma
Suzanne Leveille 152 260
Hand and knee osteoarthritis, chronic joint pain and the occurrence of falls in an older population: The MOBILIZE Boston Study.
Amy Lewandowski 147 70
Daytime activity moderates the association between daily pain and actigraphic sleep patterns in adolescents with chronic pain
Oscar Linares 226 22
Model dependence of morphine clearance measurements in humans
Ralph Lydic 223 159
Intravenous administration of buprenorphine to Sprague Dawley rat disrupts normal sleep architecture
Ralph Lydic 225 189
Microdialysis delivery of buprenorphine to rat pontine reticular formation does not alter adenosine levels
Anne Lynch-Jordan 170 204
The relationship between adolescent pain behaviors and catastrophizing on parent catastrophizing about their adolescents’ pain
Ami Mac 156 233
Coping behaviors in ethnically diverse cancer survivors
Tara Macey Paper 330/Poster 222 150
Attenuation of Akt signaling increases morphine sensitivity in the vlPAG
Ashok Mallya 261 194
Vitamin D abnormalities and supplementation in veterans receiving methadone maintenance: Effects on pain, depression, and substance misuse
Andrew Mannes 270 265
Resiniferatoxin, a potent TRPV1 agonist: Intrathecal administration to treat severe pain associated with advanced cancer Case Report
Satin Martin 328 58
Pain catastrophizing, pain sensitivity, and the menstrual cycle
Denis Martin 329 72
Facilitating acquisition of self-management skills for chronic pain: evaluation of the item structure of a graphical tool for education and performance feedback
Katherine Martucci 221 269
Early and delayed effects of intravenous administration of remifentanil and naloxone on sensitivity to thermal stimuli.
Vani Mathur 345 50
The effects of implicit racial priming on the relationship between trust and empathy for pain
Bill McCarberg 241 195
The management of opioid-related side effects in pain management from the patients' perspective
Deborah McDonald 335 59
The effect of a virtual pain coach on older adults osteoarthritis pain: A pilot study
Salimah Meghani 176 127
Choice-based Conjoint Analysis (CBC) to elicit preferences for cancer pain treatment between and among African Americans and Whites: A pilot study
Salimah Meghani 308 74
A meta-analysis of racial and ethnic disparities in analgesic treatment for pain in the United States
Wen-Li Mi 192 60
New evidence for the involvement of spinal neurotrophin-3 in the electroacupuncture analgesia and inhibition of spinal glial activation in rat model of monoarthritis
Rosemay Michel 269 227
Use of pulsed radio frequency energy in the treatment of recalcitrant plantar fasciitis
Armando Miciano 101 300
Determining the pain disability status of individuals with polytrauma history over 2 years and with chronic pain, according to the AMA Guides to the Evaluation of Permanent Impairment, Sixth Edition
Debra Miller-Saultz 280 16
Pediatric pain managment use of urine toxicology
Kendall Mitchell 259 282
Prolonged analagesic effect of RTX on A-delta type II fibers following peripheral administration.
Md. Ariful Haque Mollik 154 24
Effect of plants on the treatment of rheumatoid arthritis: a pragmatic randomized ethnomedicinal survey in Lakshmipur district of Bangladesh
Jose Monsivais 185 186
Profile of litigators with chronic limb pain in a predominantly Hispanic workers'-compensation population
Jose Monsivais 220 184
An alternate nocioceptive drive: The role of the propioceptive system in the maintenance of chronic pain
Jose Monsivais 318 187
Return to work prescription increases return to work rate in a primarily Hispanic population with Chronic Pain
Diane Monsivais 348 169
I'm just not that sick. Cultural constructions of pain medication use among Mexican American women
Diane Monsivais 349 200
I was ashamed...like it was psychological. Dangerous silence: Cultural constructions of expressing and communicating pain symptoms among Mexican American women
Kenneth Moore 273 168
Steady-state pharmacokinetic profile of OROS hydromorphone extended release and hydromorphone immediate release
Kenneth Moore 274 176
Food does not significantly affect the pharmacokinetic profile of OROS hydromorphone extended release
Benjamin Morasco 276 56
Characteristics of patients prescribed high doses of opioid medications to treat non-cancer pain.
Scott Morgan 295 29
Medication utilization before and after initiation of pregabalin treatment in patients enrolled in a commercial health plan.
Carolina Muscoli 191 276
The protective effect of bergamot derived flavonoid on the post-translational modulation of glutamate transmission: a new therapeutic approach for opioid tolerance management.
Andrea Nackley 168 303
Cytokines associated with TMD case status and related intermediate phenotypes
Michael Nemenov 115 31
Laser Diode (DL) selective pain stimulation for clinical and pre-clinical research
Lee-Lee (Hoa) Nguyen 256 45
Spinal cord stimulation improves pain intensity and interference, irrespective of pain site, device manufacturer or primary vs. revised implantation status
Noorulain Noor 310 273
Effects of ondansetron on opioid withdrawal symptoms
Candon Norton 184 65
Interdisciplinary pain training: approach and results from the VA's national training program
Danielle Orrey 145 250
Psychological characteristics associated with pain severity in the early aftermath of sexual assault
Glenn Ozoa 327 14
Catastrophizing as a predictor of outcome after cervical epidural injection for upper extremity radiculopathy
Accepted Papers
Accepted Posters:
A - E F - J K - O P - T U - Z
Guidelines For Poster Presenters